Kezar Life Valuation
| KZR Stock | USD 6.48 0.05 0.78% |
At this time, the firm appears to be undervalued. Kezar Life Sciences secures a last-minute Real Value of $8.1 per share. The latest price of the firm is $6.48. Our model forecasts the value of Kezar Life Sciences from analyzing the firm fundamentals such as Return On Equity of -0.51, shares outstanding of 7.3 M, and Operating Margin of (14.22) % as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Kezar Life's valuation include:
Undervalued
Today
Please note that Kezar Life's price fluctuation is not too volatile at this time. Calculation of the real value of Kezar Life Sciences is based on 3 months time horizon. Increasing Kezar Life's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Kezar stock is determined by what a typical buyer is willing to pay for full or partial control of Kezar Life Sciences. Since Kezar Life is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Kezar Stock. However, Kezar Life's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.48 | Real 8.1 | Target 13.5 | Hype 6.45 | Naive 6.48 |
The intrinsic value of Kezar Life's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Kezar Life's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Kezar Life Sciences helps investors to forecast how Kezar stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Kezar Life more accurately as focusing exclusively on Kezar Life's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Kezar Life's intrinsic value based on its ongoing forecasts of Kezar Life's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Kezar Life's closest peers.
Kezar Life Cash |
|
Kezar Valuation Trend
Kezar Life's real value is important for investors to make better decisions and a more accurate overall view of Kezar Life's financial worth over time. Using both Kezar Life's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Kezar Life Total Value Analysis
Kezar Life Sciences is now forecasted to have company total value of (84.56 M) with market capitalization of 47.28 M, debt of 18.93 M, and cash on hands of 306.84 M. The negative valuation of Kezar Life may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Kezar Life fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(84.56 M) | 47.28 M | 18.93 M | 306.84 M |
Kezar Life Investor Information
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.35. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Kezar Life Sciences recorded a loss per share of 13.12. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 30th of October 2024. Based on the measurements of operating efficiency obtained from Kezar Life's historical financial statements, Kezar Life Sciences may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Kezar Life Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Kezar Life has an asset utilization ratio of 3.16 percent. This connotes that the Company is making $0.0316 for each dollar of assets. An increasing asset utilization means that Kezar Life Sciences is more efficient with each dollar of assets it utilizes for everyday operations.Kezar Life Ownership Allocation
The market capitalization of Kezar Life Sciences is $47.28 Million. Over half of Kezar Life's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.Kezar Life Profitability Analysis
The company reported the last year's revenue of 7 M. Reported Net Loss for the year was (101.87 M) with loss before taxes, overhead, and interest of (72.85 M).About Kezar Life Valuation
The stock valuation mechanism determines Kezar Life's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Kezar Life Sciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Kezar Life. We calculate exposure to Kezar Life's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Kezar Life's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 6.8 M | 7.2 M | |
| Pretax Profit Margin | (13.10) | (13.75) | |
| Operating Profit Margin | (13.53) | (14.21) | |
| Net Loss | (13.10) | (13.75) | |
| Gross Profit Margin | 0.76 | 0.68 |
Kezar Life Growth Indicators
Investing in growth stocks can be very risky. If the company such as Kezar Life does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 72.6 M |
Kezar Life Current Valuation Indicators
Kezar Life's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Kezar Life's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Kezar Life, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Kezar Life's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Kezar Life's worth.Additional Tools for Kezar Stock Analysis
When running Kezar Life's price analysis, check to measure Kezar Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kezar Life is operating at the current time. Most of Kezar Life's value examination focuses on studying past and present price action to predict the probability of Kezar Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kezar Life's price. Additionally, you may evaluate how the addition of Kezar Life to your portfolios can decrease your overall portfolio volatility.